V1 |
Predicted CTL, HTL, and BCL epitopes of LEGPH protein TolB with β defensin adjuvant and PADRE sequence |
EAAAKGIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKKEAAAKAKFVAAWTLKAAAGGGSRIISLFLLLFTGGGSTSGRGGSPQVYGGGSQVIALDLELTQGGGSIGVQNTGGGPGGGSLPAREGDVQGGGSDVDLSSGSMKGGGSTFGNSIDTEGPGPGTPKIYDVDLSSGSMKQLTFGGPGPGLTFGNSIDTEPRYSPDGGPGPGFTSGRGGSPQVYRLSLAGPGPGYSLEVADADGHNPQSGPGPGRVTFEGNYNARASYTGPGPGGGRSRYSLEVADADGGPGPGISGPQGANSQSSVSTGPGPGVIALDLELTQGINSAKKSGPQGANSQSSVKKAREGDVQEPAWSPYKKSWSPNGKKKSGRGGSPKKSFEKKKAKKIDTEPRYSPDGKKADGQISRKKIISLFLLLFTGQVIALDLEKKGQHLAVVLSKKKYSPDGRSKKAKFVAAWTLKAAAGGGS
|
Nonallergen |
0.6034 |
V2 |
Predicted CTL, HTL, and BCL epitopes of LEGPH protein TolB with L7/L12 ribosomal protein adjuvant and PADRE sequence |
EAAAKMAKLSTDELLDAFKEMTLLELSDFVKKFEETFEVTAAAPVAVAAAGAAPAGAAVEAAEEQSEFDVILEAAGDKKIGVIKVVREIVSGLGLKEAKDLVDGAPKPLLEKVAKEAADEAKAKLEAAGATVTVKEAAAKAKFVAAWTLKAAAGGGSRIISLFLLLFTGGGSTSGRGGSPQVYGGGSQVIALDLELTQGGGSIGVQNTGGGPGGGSLPAREGDVQGGGSDVDLSSGSMKGGGSTFGNSIDTEGPGPGTPKIYDVDLSSGSMKQLTFGGPGPGLTFGNSIDTEPRYSPDGGPGPGFTSGRGGSPQVYRLSLAGPGPGYSLEVADADGHNPQSGPGPGRVTFEGNYNARASYTGPGPGGGRSRYSLEVADADGGPGPGISGPQGANSQSSVSTGPGPGVIALDLELTQGINSAKKSGPQGANSQSSVKKAREGDVQEPAWSPYKKSWSPNGKKKSGRGGSPKKSFEKKKAKKIDTEPRYSPDGKKADGQISRKKIISLFLLLFTGQVIALDLEKKGQHLAVVLSKKKYSPDGRSKKAKFVAAWTLKAAAGGGS
|
Nonallergen |
0.5524 |
V3 |
Predicted CTL, HTL, and BCL epitopes of LEGPH protein TolB with HABA adjuvant and PADRE sequence |
EAAAKMAENPNIDDLPAPLLAALGAADLALATVNDLIANLRERAEETRAETRTRVEERRARLTKFQEDLPEQFIELRDKFTTEELRKAAEGYLEAATNRYNELVERGEAALQRLRSQTAFEDASARAEGYVDQAVELTQEALGTVASQTRAVGERAAKLVGIELEAAAKAKFVAAWTLKAAAGGGSRIISLFLLLFTGGGSTSGRGGSPQVYGGGSQVIALDLELTQGGGSIGVQNTGGGPGGGSLPAREGDVQGGGSDVDLSSGSMKGGGSTFGNSIDTEGPGPGTPKIYDVDLSSGSMKQLTFGGPGPGLTFGNSIDTEPRYSPDGGPGPGFTSGRGGSPQVYRLSLAGPGPGYSLEVADADGHNPQSGPGPGRVTFEGNYNARASYTGPGPGGGRSRYSLEVADADGGPGPGISGPQGANSQSSVSTGPGPGVIALDLELTQGINSAKKSGPQGANSQSSVKKAREGDVQEPAWSPYKKSWSPNGKKKSGRGGSPKKSFEKKKAKKIDTEPRYSPDGKKADGQISRKKIISLFLLLFTGQVIALDLEKKGQHLAVVLSKKKYSPDGRSKKAKFVAAWTLKAAAGGGS
|
Nonallergen |
0.5726 |